ArticleAntimicrobial agents and chemotherapy2019

A First-in-Human Study To Assess the Safety and Pharmacokinetics of LYS228, a Novel Intravenous Monobactam Antibiotic in Healthy Volunteers.

Megan Osborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.